INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Trinity Biotech plc and Advises Investors with Losses to Contact
the Firm
Goldberg Law PC announces that it is investigating Trinity Biotech plc (“Trinity” or the “Company”) (Nasdaq:
TRIB) concerning possible violations of federal securities laws.
If you purchased or otherwise acquired Trinity shares and would like more information regarding the investigation, we advise you
to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los
Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by e-mail at info@goldberglawpc.com.
The investigation concerns whether Chesapeake and certain of its officers and/or directors violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934. On October 4, 2016, the Company announced that it will withdraw its 510(k) premarket
notification submission for the Meritas Troponin-I Test and Meritas Point-of-Care Analyzer on the advice of the U.S. Food &
Drug Administration. The Company also stated that it would reduce spending by nearly 85% and that it would close a Swedish
facility, thus eliminating 40 jobs. When this news was announced, shares of Trinity fell in value.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or e-mail us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006531/en/